Gleamer Charts Multi-Modality Future With FDA Nod And MRI Acquisitions
The French Start-up Is Laying Groundwork For A Full-Suite Diagnostic Platform Across X-Ray, CT And MRI.
The FDA clearance expands Gleamer’s Copilot suite footprint in the US market. 
